| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.0068 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0043 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.0031 | 1 |